Phase IIb Trial of Recombinant Novel Coronavirus Vaccine (Ad5-nCoV) in Adults 18 Years of Age and Older, Living With HIV
Clinical trial NCT05005156 · COMPLETED
Trial details
- NCT number
- NCT05005156
- Sponsor
- Fundación Huésped
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-24
- Primary completion
- 2023-01-13
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.